US2017320826A1PendingUtilityA1

Bivalent linkers and conjugates thereof

Assignee: ENDOCYTE INCPriority: Jul 23, 2004Filed: Jan 23, 2017Published: Nov 9, 2017
Est. expiryJul 23, 2024(expired)· nominal 20-yr term from priority
A61P 43/00A61K 49/0002C07D 401/12A61K 47/551C07D 475/04C07D 213/71A61K 47/6803
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Bivalent linkers to be included in or for preparing vitamin, drug, diagnostic agent, and/or imaging agent conjugates are described.

Claims

exact text as granted — not AI-modified
1 - 6 . (canceled) 
     
     
         7 . A compound of a formula selected from the group consisting of 
       
         
           
           
               
               
           
         
       
       wherein
 D is a drug; 
 X 1  and X 2  are each independently a leaving group displaceable by a nucleophile; 
 R a  and R b  are each independently hydrogen or alkyl; or R a  and R b  are taken together with the attached carbon atom to form a carbocyclic ring; 
 L 1  and L 2  are each independently selected bivalent linkers; and 
 n is an integer from 1 to about 4. 
 
     
     
         8 . The compound of  claim 7 , wherein X 1  is optionally substituted heteroarylthio. 
     
     
         9 . The compound of  claim 7 , wherein X 1  is optionally substituted 2-pyridinylthio or optionally substituted 4-pyridinylthio. 
     
     
         10 . The compound of  claim 7 , wherein X 1  is substituted by at least one electron withdrawing substituent selected from the group consisting of cyano, nitro, alkylsulfonyl, arylsulfonyl, halo, haloalkyl, acyl, and carboxyl. 
     
     
         11 . The compound of  claim 7 , wherein X 1  is substituted by a nitro group. 
     
     
         12 . The compound of  claim 7 , wherein X 1  is selected from the group consisting of 
       
         
           
           
               
               
           
         
       
       where * represents the point of attachment. 
     
     
         13 . The compound of  claim 7 , wherein X 1  is 
       
         
           
           
               
               
           
         
       
       where * represents the point of attachment. 
     
     
         14 . The compound of  claim 7 , wherein n is 1. 
     
     
         15 . The compound of  claim 7 , wherein R a  and R b  are each independently hydrogen or lower alkyl. 
     
     
         16 . The compound of  claim 7 , wherein R a  and R b  are each hydrogen. 
     
     
         17 . The compound of  claim 7 , wherein R a  and R b  are taken together with the attached carbon atom to form a carbocyclic ring. 
     
     
         18 . The compound of  claim 7 , wherein R a  and R b  are taken together with the attached carbon atom to form cyclopropyl. 
     
     
         19 . The compound of  claim 7 , wherein the compound is of the formula 
       
         
           
           
               
               
           
         
       
     
     
         20 . The compound of  claim 7 , wherein the compound is of the formula

Join the waitlist — get patent alerts

Track US2017320826A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.